Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10870535 | FEBS Letters | 2015 | 10 Pages |
Abstract
Urokinase type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1) have been proposed to play key roles in extracellular matrix (ECM) deposition in hypertrophic scars (HS). Here, we found that in HS fibroblasts (HFs) miR-181c and miR-10a were differentially-expressed and targeted uPA and PAI-1, respectively. The production of Type 1 collagen (Col1) was inhibited by miR-181c knockdown or miR-10a overexpression in HFs, and this resulted in increased levels of metalloproteinase 1 (MMP1). These results suggest that the miR-181c-uPA and miR-10a-PAI-1 regulatory pathways have an integral role in HS pathogenesis.
Keywords
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Chao Li, Hua-Yu Zhu, Wen-Dong Bai, Lin-Lin Su, Jia-Qi Liu, Wei-Xia Cai, Bin Zhao, Jian-Xin Gao, Shi-Chao Han, Jun Li, Da-Hai Hu,